Adverum Biotechnologies grants stock options and RSUs to new employees under Inducement Plan.

From GlobeNewswire: 2025-02-28 16:00:00

Adverum Biotechnologies, Inc. granted 44,380 stock options and 22,790 RSUs to 5 new employees under the 2017 Inducement Plan. Stock options have an exercise price of $4.20 per share and will vest over four years. RSUs will vest over three years, with one-third of the shares vesting each year. Adverum aims to develop gene therapy to preserve sight in ocular diseases, including neovascular or wet age-related macular degeneration, with the goal of creating functional cures. The company’s goal is to transform the standard of care, preserve vision, and prevent blindness. For more information, visit www.adverum.com.



Read more at GlobeNewswire: Adverum Biotechnologies Reports Inducement Grants Under